Affordable Access

Access to the full text

The Selenoprotein MsrB1 Instructs Dendritic Cells to Induce T-Helper 1 Immune Responses

Authors
  • Lee, Ho-Jae
  • Park, Joon Seok
  • Yoo, Hyun Jung1
  • Lee, Hae Min1
  • Lee, Byung Cheon1
  • Kim, Ji Hyung1
  • 1 (B.C.L.)
Type
Published Article
Journal
Antioxidants
Publisher
MDPI AG
Publication Date
Oct 20, 2020
Volume
9
Issue
10
Identifiers
DOI: 10.3390/antiox9101021
PMID: 33092166
PMCID: PMC7589095
Source
PubMed Central
Keywords
License
Green

Abstract

Immune activation associates with the intracellular generation of reactive oxygen species (ROS). To elicit effective immune responses, ROS levels must be balanced. Emerging evidence shows that ROS-mediated signal transduction can be regulated by selenoproteins such as methionine sulfoxide reductase B1 (MsrB1). However, how the selenoprotein shapes immunity remains poorly understood. Here, we demonstrated that MsrB1 plays a crucial role in the ability of dendritic cells (DCs) to provide the antigen presentation and costimulation that are needed for cluster of differentiation antigen four (CD4) T-cell priming in mice. We found that MsrB1 regulated signal transducer and activator of transcription-6 (STAT6) phosphorylation in DCs. Moreover, both in vitro and in vivo, MsrB1 potentiated the lipopolysaccharide (LPS)-induced Interleukin-12 (IL-12) production by DCs and drove T-helper 1 (Th1) differentiation after immunization. We propose that MsrB1 activates the STAT6 pathway in DCs, thereby inducing the DC maturation and IL-12 production that promotes Th1 differentiation. Additionally, we showed that MsrB1 promoted follicular helper T-cell (Tfh) differentiation when mice were immunized with sheep red blood cells. This study unveils as yet unappreciated roles of the MsrB1 selenoprotein in the innate control of adaptive immunity. Targeting MsrB1 may have therapeutic potential in terms of controlling immune reactions.

Report this publication

Statistics

Seen <100 times